ZOM - Zomedica acquires assets of Assisi Animal Health LLC
- Zomedica ( NYSE: ZOM ) has acquired Assisi Animal Health LLC.
- Financial terms were not disclosed.
- "This acquisition adds a growing product line that furthers our commitment to providing solutions that deliver enhanced companion animal care, while improving practice efficiency and economics," said Zomedica's Chief Executive Officer, Larry Heaton. "The Assisi products fit nicely into our growing therapeutics segment. They are complementary with PulseVet® Shock Wave therapy, in that they are designed to be used after shock wave therapy is delivered in the clinic, by the pet parent at home, and are provided by Veterinarians to pet parents to extend the therapy. We are pleased to offer an additional drug-free solution to improve our pets' ability to live pain free."
- Assisi has created an innovative line of targeted Pulsed Electromagnetic Field (tPEMF) devices for companion animals that provide a safe, drug-free alternative for treating pain, inflammation, anxiety, or behavioral disorders.
- Shares down 0.8% PM.
For further details see:
Zomedica acquires assets of Assisi Animal Health LLC